Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M512283200 on December 6, 2005

J. Biol. Chem., Vol. 281, Issue 7, 4035-4041, February 17, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/7/4035    most recent
M512283200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwata, J.-i.
Right arrow Articles by Kominami, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwata, J.-i.
Right arrow Articles by Kominami, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Excess Peroxisomes Are Degraded by Autophagic Machinery in Mammals*

Jun-ichi Iwata{ddagger}§1, Junji Ezaki{ddagger}1, Masaaki Komatsu{ddagger}§, Sadaki Yokota, Takashi Ueno{ddagger}, Isei Tanida{ddagger}, Tomoki Chiba§, Keiji Tanaka§, and Eiki Kominami{ddagger}2

From the {ddagger}Department of Biochemistry, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-8421, the §Department of Molecular Oncology, Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113-8613, and the Biology Laboratory, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Tamaho-machi, Yamanashi 409-38, Japan

Received for publication, November 15, 2005


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Peroxisomes are degraded by autophagic machinery termed "pexophagy" in yeast; however, whether this is essential for peroxisome degradation in mammals remains unknown. Here we have shown that Atg7, an essential gene for autophagy, plays a pivotal role in the degradation of excess peroxisomes in mammals. Following induction of peroxisomes by a 2-week treatment with phthalate esters in control and Atg7-deficient livers, peroxisomal degradation was monitored within 1 week after discontinuation of phthalate esters. Although most of the excess peroxisomes in the control liver were selectively degraded within 1 week, this rapid removal was exclusively impaired in the mutant liver. Furthermore, morphological analysis revealed that surplus peroxisomes, but not mutant hepatocytes, were surrounded by autophagosomes in the control. Our results indicated that the autophagic machinery is essential for the selective clearance of excess peroxisomes in mammals. This is the first direct evidence for the contribution of autophagic machinery in peroxisomal degradation in mammals.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Reorganization of organelles constitutively or suddenly occurs in eukaryotic cells as an adaptation to environmental changes accompanying the cell cycle, development, and differentiation (1). Such alterations are stringently regulated by biogenesis and/or degradation. In the last decade, much attention was paid to the study of organelle assembly, an interest linked with the translocation of proteins into the organelles (2). One focus of that work was peroxisomes. Peroxisomes are single membrane-bound organelles that contribute to an array of metabolic pathways and are specifically and markedly induced by a group of nongenotoxic carcinogens and endogenous steroids in rodents (3-6). Indeed, peroxisome proliferators increase the size, number, and enzymes involved in fatty acid metabolism: e.g. peroxisomal thiolase (PT),3 peroxisomal bifunctional protein (BF), and fatty acid beta-oxidation of peroxisomes (7, 8). However, the mechanistic basis of peroxisome turnover remains poorly understood (8, 9).

In yeast species, such as Pichia pastoris, Hansenula polymorpha, Candida boidinii, and Saccharomyces cerevisiae, proliferating peroxisomes are degenerated by an autophagy-related process named pexophagy during glucose or ethanol adaptation (10–14). Yeast genetics of pexophagy revealed that most autophagy-related (Atg) genes play indispensable roles in this selective degradation of peroxisomes as well as autophagy (8, 9, 13, 15, 16). In mammals, however, whether or not the autophagic machinery is involved in the degradation of excess peroxisomes biosynthesized in response to drug cues remains a mystery. In particular, there is no direct evidence for the degradation of disused peroxisomes by the autophagic machinery, and it is not clear whether such a degradation process, if any, is selective or non-selective. It has also been reported that selective degradation of mitochondria may occur via autophagy-related mechanism in yeast (17, 18). Therefore, selectivity in the organelle turnover via autophagy is an important issue.

Among the many Atg genes that regulate autophagy, Atg7, which encodes a ubiquitin-activating enzyme (E1)-like enzyme common to two ubiquitylation-like conjugations, the LC3 (Atg8 in yeast) and Atg12 conjugation systems, is a critical gene for autophagosome formation in yeast and mammalian cells (19–26). It has been reported that in yeast, Atg7/Apg7/Gsa7 is essential for pexophagy in addition to autophagy (19, 22, 24). During mammalian autophagy, LC3-I (a cytosolic form of LC3) is lipidated to LC3-II (its autophagosomal membrane-bound form) by Atg7 (an E1-like enzyme) and Atg3 (a ubiquitin carrier protein (E2)-like enzyme) (21, 27). Recently, we have established conditional knock-out-mice of Atg7 and have shown that Atg7 is indispensable for mammalian autophagy and that the autophagy deficiency in liver leads to marked accumulation of cytoplasmic proteins (20). In the normal liver, LC3 is continuously synthesized to form LC3-I, and LC3-I is subsequently conjugated with phosphatidylethanolamine to form LC3-II during autophagy. LC3-II is then recruited to autophagosomal membranes (21, 28), and the autophagosomal LC3-II is rapidly degraded after fusion of autophagosome with lysosome (29). This dynamic flow of LC3 is completely inhibited in Atg7-deficient liver and, as a consequence, more LC3-I accumulates in the mutant liver (20). Considering that deletion of yeast Atg7/Gsa7 gene results in a defect of pexophagy in P. pastoris (24), the liver-specific Atg7-conditional knock-out mice will be an advantageous tool in investigating the degradation of peroxisomes in mammals.

In this study, we analyzed the clearance of surplus peroxisomes using the conditional-knock-out mice of Atg7 (20). The results indicated that autophagy is essential for the degradation of accumulated peroxisomes in the mouse liver.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Reagents—Phthalate esters (diethylhexyl phthalate (DEHP)), corn oil, and leupeptin were purchased from Sigma.


Figure 1
View larger version (66K):
[in this window]
[in a new window]
  		FIGURE 1.
The recovery process of excess peroxisomes induced by DEHP treatment. A, wild-type mice were treated with DEHP for 2 weeks (2 w DEHP) and then chased for 1 week (2 w DEHP + 1w). Untreated and treated mice were dissected, and liver homogenates were fractionated into MLP, microsomal (Ms), and cytosolic (Cyt) fractions. The protein amount in each fraction was measured. Data are mean ± S.D. values of five mice in each group; *, p < 0.02 and ***, p < 0.001. B, wild-type mice were treated as described in A. The vehiclecontrol mice were treated with corn oil for 2 weeks (2 w vehicle). Untreated and treated mice were sacrificed, and the livers were dissected out and homogenized, and then the postnuclear supernatant fractions were subjected to immunoblotting with anti-PT, BF, beta-subunit ATP synthase, Mn2+-superoxide dismutase (SOD), BiP, and tubulin antibodies. Tubulin was used as a control. Data shown are representative of three separate experiments. C, quantitative densitometry of immunoblotting data in B was performed, and the ratios between each of PT, BF, and ATP synthase and tubulin were plotted; **, p < 0.01, ***, p < 0.001. D, wild-type mice were treated with DEHP as described in A, and the frozen sections of livers were stained with anti-PT antibody to detect peroxisomes. Magnification, x400.

 
Animals and Treatment Regimen—C57B6J mice were used as wild-type mice. Male mice received DEHP (1,150 mg/kg/day) or vehicle (corn oil, 5 ml/kg/day) via sonde daily for 2 weeks, and the mice were subsequently fed on a normal diet for 1 week to investigate the changes in proliferated peroxisomes during the recovery process according to the protocol reported previously (7). For detection of autophagosomes by electron microscopy, mice were injected with leupeptin (2 mg/100 g of body weight) after administration of DEHP. All animals were sacrificed by deep anesthesia.

Deletion of Atg7 in Mouse Liver—Atg7 conditional knock-out mice and the heterozygotes were prepared as described previously (20). Briefly, creatine expression in the liver was induced by intraperitoneal injection of polyinosinic acid-polycytidylic acid (pIpC). pIpC was injected three times at a 48-h interval.

Preparation of the Fractions—Livers from Atg7F/+:Mx1 and Atg7F/F:Mx1 mice were treated with DEHP or corn oil for 2 weeks, and at 1 week after treatment, they were dissected. Subfractionation of the livers was accomplished by differential centrifugation according to the method of de Duve et al. (30). Briefly, 20% homogenates were prepared in 0.25 M sucrose, 10 mM HEPES-NaOH, pH 7.4 (homogenizing buffer). The homogenate of the liver was centrifuged at 650 x g for 5 min to remove nuclei and unbroken cells. The pellets were resuspended in the same volume of homogenizing buffer and were then recentrifuged. The supernatants from these two centrifugations were combined and used as postnuclear supernatant fractions. Postnuclear supernatant fractions were centrifuged at 10,000 x g for 20 min, and pellets were used as the mitochondrial/lysosomal/peroxisomal (MLP) fractions. The post-MLP supernatants were further centrifuged at 105,000 x g for 60 min to precipitate microsomal fractions in pellet form. All procedures were performed at 4 °C.

Immunoblot Analysis—Immunoblotting was performed as described previously (19). The antibody against Mn2+-superoxide dismutase was kindly provided by Prof. Naoyuki Taniguchi (Osaka University, Japan). The antibodies for Atg7 (19), LC3 (20), BF (31), PT (32), and the beta-subunit of ATP synthase (33) were prepared as described previously. The antibodies against tubulin and BiP were purchased from Chemicon International, Inc. (Temecula, CA) and Affinity BioReagents, Inc. (Golden, CO), respectively.

Histological Examination—Livers were dissected, fixed in 4% paraformaldehyde, frozen, embedded, and sectioned. For immunohistochemical analysis, the sections were blocked with 5% normal goat serum in phosphate-buffered saline containing 0.2% Triton X-100 and then incubated with anti-PT antibody and Alexa Fluor 488-labeled second antibody (Molecular Probes, Eugene, OR). Fluorescence images were obtained using a fluorescence microscope (Q550FV; Leica, Germany) equipped with cooled charge-coupled device camera (CTR MIC; Leica). Pictures were taken using Leica Qfluoro software (Leica).

Electron Microscopy—Livers were perfusion-fixed with the fixative through the portal vein for 10 min. The fixative consisted of 2% paraformaldehyde, 1% glutaraldehyde, and 0.1 M HEPES-KOH buffer (pH 7.4). To visualize peroxisomes, some liver slices were incubated in alkaline 3,3-diaminobendine medium consisting of 2 mg/ml 3,3-diaminobendine, 0.02% hydrogen peroxide, and 0.2 M glycine-NaOH buffer (pH 10.0) for 1 h at room temperature. Then they were postfixed with 1% reduced osmium tetroxide for 1 h. The other tissue slices were postfixed in 1% reduced osmium tetroxide with 3,3-diaminobendine reaction. All tissue slices were then dehydrated in graded series of ethanol and embedded in Epon. Thin sections were cut with a diamond knife using an ultramicrotome (Reichert, Vienna, Austria). Sections were contrasted with 40 mM lead citrate for 5 min and examined with a Hitachi H7500 electron microscope (Hitachi, Tokyo, Japan).

Quantitative Analysis of Peroxisomes—For each tissue slice, 20 digital electron micrographs were acquired at x5,000 magnification, enlarged 2.7-fold, and printed by a laser printer. Using the printed figure, we measured the area of peroxisomes and that of the cytoplasmic area of hepatocytes using a SigmaScan scientific measurement system equipped with a computer (Jandel Scientific, San Rafael, CA). The relative total area of peroxisomes was calculated using the following formula: (number of peroxisomes in the average area of peroxisomes/cytoplasmic area) and expressed in µm2/100 µm2 of cytoplasmic area.

Statistical Analysis—The statistical significance of differences between experimental and control groups was determined by the two-tailed Student's t test. A p value of <0.05 was considered statistically significant.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Selective Degradation of Excess Peroxisomes—Phthalate ester (DEHP) and its active metabolite mono-ethylhexyl phthalate can cause marked increases in both the size and the number of peroxisomes and induce peroxisomal enzymes in the liver (7). Utilizing these phenomena, we first investigated the specific proliferation of peroxisomes and the rapid recovery after removal of the drugs in mice. Wild-type mice were treated with DEHP for 2 weeks and then chased for 1 week as described under "Experimental Procedures." The mice were dissected at each period, and the liver cell lysates were fractionated into MLP, microsomal, and cytosolic fractions. DEHP administration for 2 weeks was associated with about 2-fold increase in the amount of total protein in MLP, but not in microsomal or cytosolic fractions, as compared with untreated mice, and the amount almost returned to the basal level at 1 week after discontinuation of DEHP (Fig. 1A). These changes were not observed in mice treated with the vehicle (data not shown). Quantitative densitometric analysis of immunoblotting data revealed that PT and BF, marker proteins of peroxisomes, increased significantly after administration of DEHP but not the vehicle, and both diminished significantly to basal levels at 1 week after DEHP discontinuation (Fig. 1, B and C). In comparison, the levels of mitochondrial proteins, the beta-subunit of ATP synthase and manganese superoxide dismutase, and the endoplasmic reticulum marker, BiP, remained unchanged during the same manipulations (Fig. 1B). Immunofluorescence analysis using anti-PT antibody revealed that a 2-week administration of DEHP, but not the vehicle, resulted in the appearance of numerous dots representing peroxisomes, and most of these dots disappeared at 1 week after discontinuation of DEHP (Fig. 1D). Considered together, these results indicate that DEHP-induced peroxisomes are selectively degraded following removal of the peroxisome proliferator.

Impairment of Degradation of Proliferated Peroxisomes in Autophagy-deficient Liver—Next, to examine the effects of autophagy deficiency on peroxisome degradation, we took advantage of the conditional knock-out mice, Atg7F/F:Mx1 (mutant mice), and their littermates, Atg7F/+:Mx1 mice (control mice), the systems of which were recently established by our group (20). Autophagy is impaired following pIpC injection in Atg7F/F:Mx1 mouse livers. Indeed, we verified that Atg7 protein deletion in Atg7F/F:Mx1 but not Atg7F/+:Mx1 livers was pIpC injection-dependent (Fig. 2A). Furthermore, we also tested the loss of Atg7 activity by investigating the lack of LC3-II (a membrane-bound form of LC3) and accumulation of LC3-I (a cytosolic form of LC3) in the liver. It is generally accepted that LC3-II is a marker protein of autophagosomal membranes (21). Although both forms were detected in the control liver, only LC3-I accumulated in the mutant liver (Fig. 2A), indicating impairment of autophagy in mutant Atg7F/F:Mx1 mouse liver (20). In the control livers, although LC3-II were induced by the proliferated peroxisomes (Fig. 2A, indicated by 2 w DEHP), it was decreased almost to the basal levels at 1 week after withdrawal of DEHP (Fig. 2A), suggesting that autophagy was induced to remove surplus peroxisomes. After a 2-week treatment with DEHP, the livers were dissected, and total proteins in the lysates of mutant and control livers were separated by SDS-PAGE and subjected to immunoblot analyses. Similar to the results obtained with wild-type mice (Fig. 1), BF and PT increased profoundly after the treatment as compared with mice prior to DEHP administration and then decreased almost to the basal levels at 1 week after discontinuation in Atg7F/+:Mx1 livers (Fig. 2, A and B). Although this increase was also detected in mutant Atg7F/F:Mx1 livers, the increased PT and BT proteins did not return to the basal levels following the discontinuation of DEHP (Fig. 2, A and B). In contrast to peroxisomal proteins, the levels of mitochondrial (beta-subunit of ATP synthase and Mn2+-superoxide dismutase) and endoplasmic reticulum (BiP) markers did not change under these conditions (Fig. 2, A and B). These results indicate selective impairment of degradation of excess peroxisomal proteins in autophagy-deficient Atg7F/F:Mx1 liver.


Figure 2
View larger version (82K):
[in this window]
[in a new window]
  		FIGURE 2.
The recovery process of excess peroxisomes is impaired in Atg7-deficient liver. A, Atg7F/+:Mx1 (F/+:Mx1) and Atg7F/F:Mx1 (F/F:Mx1) mice were treated with DEHP for 2 weeks (2 w DEHP) and then chased for 1 week (2 w DEHP + 1w). Both genotype mice were sacrificed at each time point. The liver was dissected out and homogenized, and then the postnuclear supernatant fractions were subjected to immunoblotting using anti-Atg7, LC3, BF, PT, beta-subunit ATP synthase, Mn2+-superoxide dismutase (SOD), BiP, and tubulin antibodies. Tubulin was used as control. Data shown are representative of three separate experiments. B, quantitative densitometry of Western blotting shown in A was performed, and PT/tubulin, BF/tubulin, beta-subunit ATP synthase/tubulin, and Mn2+-superoxide dismutase/tubulin ratios were plotted; *, p < 0.02, **, p < 0.01, NS; not significant.

 


Figure 3
View larger version (85K):
[in this window]
[in a new window]
  		FIGURE 3.
Accumulation of excess peroxisomes in Atg7-deficient liver. Immunofluorescent detection of peroxisomes with anti-PT antibody in the Atg7F/+:Mx1 (A–C, F/+: Mx1) and Atg7F/F:Mx1 (D–F, F/F:Mx1) liver is shown. Atg7F/+:Mx1 and Atg7F/F:Mx1 mice were treated with DEHP for 2 weeks (B and E, 2 w DEHP) and then chased for 1 week (C and F, 2 w DEHP + 1 w). Untreated (A and D) and treated mice were sacrificed, and the livers were isolated. The frozen sections of livers were immunostained with anti-PT antibody. Magnification, x400.

 
We further confirmed the impairment of peroxisome degradation in autophagy-deficient liver by immunofluorescence analysis using anti-PT antibody (Fig. 3). The PT-positive dots representing peroxisomes were markedly increased following a 2-week DEHP treatment in both genotype livers, as compared with untreated mice (Fig. 3, A and D versus B and E). Although the dots almost disappeared to the basal levels at 7 days after discontinuation of DEHP in the control (Fig. 3C), most of the peroxisome dots remained visible in mutant liver after the same intervention (Fig. 3F). The data are in agreement with the biochemical results shown in Fig. 2. Based on these results, we concluded that autophagy is essential for selective degradation of excess peroxisomes.

Engulfment of Excess Peroxisomes by Autophagosomal Membranes in Control Hepatocytes—Finally, we used electron microscopy to explore the level of the peroxisomes in Atg7F/F:Mx1 and Atg7F/+:Mx1 livers (Fig. 4). Consistent with the results of immunofluorescent analysis, numerous peroxisomes were detected following a 2-week DEHP treatment in both wild and mutant hepatocytes (Fig. 4, B and E), and most of these structures disappeared after 1 week of discontinuation of DEHP in the control, but not mutant, hepatocytes (Fig. 4, C and F). The relative total area of peroxisomes was determined, and the mean values are shown in Fig. 4G. Although the relative total area of peroxisomes increased in both groups after a 2-week DEHP administration, the area decreased to the basal level in control hepatocytes, but not in mutant hepatocytes, at 1 week after DEHP withdrawal from the diet (Fig. 2G).


Figure 4
View larger version (96K):
[in this window]
[in a new window]
  		FIGURE 4.
Electron microscopic evaluation of livers of Atg7-deficient mice treated with DEHP. A–F, electron micrographs of the liver of representative Atg7F/+:Mx1 mice (F/+:Mx1) and Atg7F/F:Mx1 (F/F:Mx1) mice treated with DEHP for 2 weeks (B and E, 2 w DEHP) and then fed on normal diet for 1 week (C and F, 2 w DEHP + 1 w). The vehicle control mice of each genotype were treated with corn oil for 2 weeks (A and D). The hepatocytes of both genotypes contained a high number of peroxisomes (P) after DEHP treatment (B and E). Note that induced peroxisomes were retained at 1 week after discontinuation of DEHP in Atg7F/F:Mx1 hepatocytes, in contrast to the decreased number in Atg7F/+:Mx1 hepatocytes (C and F). Bars,1 µm. The total area of peroxisomes relative to the cytoplasmic area was determined in each genotype (n = 10). M, mitochondria; G, morphometric analysis of peroxisomes in Atg7F/+:Mx1 and Atg7F/F:Mx1 mice.

 
After discontinuation of DEHP, we detected only a few autophagosome-like structures in control hepatocytes, probably due to the rapid turnover of autophagosomes by lysosome (Fig. 4C). Considering the selective degradation of peroxisomal marker proteins, PT and BF (Fig. 2), autophagosomes that selectively enwrap peroxisomes could be observed by electron microscopic analysis when lysosomal proteolysis is inhibited. Therefore, we examined whether proliferated peroxisomes enclosed by autophagosomal membranes can be detected under the condition of inhibited autophagic proteolysis. Injection of leupeptin, a lysosomal cysteine proteinase inhibitor, into a 2-week DEHP-treated control Atg7F/+:Mx1 mouse resulted in marked accumulation of autophagosomes, and some peroxisomes were surrounded by a double-membrane structure, autophagosome, in control hepatocytes (Fig. 5). No autophagosome was identified in hepatocytes of Atg7F/F:Mx1 mice (data not shown). These lines of evidence indicated that the autophagic machinery mediated is essential for selective clearance of excess peroxisomes, as it is so for starvation-induced autophagy in the mouse liver.


Figure 5
View larger version (61K):
[in this window]
[in a new window]
  		FIGURE 5.
Excess peroxisomes are surrounded by autophagosome. Atg7F/+:Mx1 mice were treated with DEHP for 2 weeks and then injected with leupeptin as described under "Experimental Procedures." The mice were sacrificed, and the livers were dissected out and processed for electron microscopic examination. These images show representative autophagosomes surrounding peroxisomes. Four typical electron micrographs are represented. Arrowheads indicate the engulfment of peroxisome(s) by isolated membranes. Bars,1 µm.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
Most cellular components, if not all, are regulated quantitatively to maintain cell homeostasis. For this regulation, there are growing lines of evidence for the importance of the balance between biosynthesis and degradation. Peroxisomes, a typical cellular component, are dynamic organelles induced and degraded in response to extracellular cues (8). However, little is known about the mechanism for peroxisome degradation in mammals. There are two major concepts for degradation of peroxisomes, i.e. autophagic machinery and autolysis (34, 35). By the analysis of autophagy-deficient livers, we showed the first direct evidence that peroxisomal breakdown is mainly, if not entirely, dependent on autophagic machinery. Based on quantitative densitometry with two peroxisomemarker enzymes (Fig. 2, PT and BF) as well as morphometry of the electron micrographs (Fig. 4), ~70–80% of peroxisomes induced by DEHP were degraded via autophagy during 1 week after discontinuation of the drug administration.

Considering peroxisome degradation by autophagic machinery in mammals, it is important to know whether the process occurs via micropexophagy or macropexophagy. In methylotrophic yeast species, it is well established that the autophagy-related process, termed pexophagy, induces a rapid and selective degradation of excess peroxisomes (13). In P. pastoris cells, following a shift from methanol to ethanol or glucose, unnecessary peroxisomes are degraded by macropexophagy and micropexophagy, respectively (9). Macropexophagy is the degradation pathway in which autophagosomes selectively surround excess peroxisomes. On the other hand, in micropexophagy, the excess peroxisomes are not degraded through autophagosome formation. The initial step in micropexophagy is invagination and septation of a vacuole followed by engulfment of the peroxisomes by the vacuole. In the final stage, the edges of the vacuole fuse with each other followed by vacuolar degradation of the peroxisomal membrane and its contents. Because ATG7 is essential for both macropexophagy and micropexophagy in P. pastoris cells, it is plausible that excess peroxisomes in mammalian cells are also degraded by both macroautophagy and micropexophagy. Our data using electron microscopy revealed that autophagosomes preferentially surrounded excess peroxisomes in control hepatocytes (Fig. 5), suggesting that DEHP-induced peroxisomes are degraded mainly through the process of macropexophagy. Thus, we could show the selective role of autophagic machinery in the clearance of surplus peroxisomes after induction of peroxisomes by phthalate esters.

Recent studies provided evidence for the involvement of the autophagic machinery in selective sequestration of proteins in the cell. For example, the precursor form of aminopeptidase I (prApe1) is a selective cargo molecule of autophagy in yeast (36), and cytosolic acetaldehyde dehydrogenase (Ald6p) is preferentially transported to vacuoles via autophagosomes in yeast (37). Consistently, the autophagic machinery could also selectively eliminate pathogenic group A Streptococci invading the cells (38). These reports strongly suggest that autophagosomes sequester the cytosolic protein(s) and invading pathogens in a highly selective manner. We recently reported that Atg7-deficient hepatocytes exhibit impaired constitutive autophagy responsible for selective degradation of ubiquitinated proteins (20). Our previous findings together with the present results suggest that the autophagic process eliminates abnormal and/or excess proteins and organelles including peroxisomes in a selective manner even under normal conditions. How the autophagy machinery recognizes these organelles to degrade them awaits further investigation.


   FOOTNOTES
 
* This work was supported by Grants-in-aid 15032263, 16790195, 15590254, 09680629, and 1270040 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Both authors contributed equally to this work. Back

2 To whom correspondence should be addressed: Dept. of Biochemistry, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. Tel.: 81-3-5802-1031; Fax: 81-3-5802-5889; E-mail: komilabo{at}med.juntendo.ac.jp.

3 The abbreviations used are: PT, peroxisomal thiolase; BF, bifunctional protein; DEHP, diethylhexyl phthalate; MLP, mitochondrial/lysosomal/peroxisomal; Atg, autophagyrelated; BiP, binding protein; pIpC, polyinosinic acid-polycytidylic acid. Back


   ACKNOWLEDGMENTS
 
We thank Tsuguka Kouno for technical assistance.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Lazarow, P. B., and Fujiki, Y. (1985) Annu. Rev. Cell Biol. 1, 489–530[CrossRef][Medline] [Order article via Infotrieve]
  2. Heiland, I., and Erdmann, R. (2005) FEBS J. 272, 2362–2372[CrossRef][Medline] [Order article via Infotrieve]
  3. Reddy, J. K., Azarnoff, D. L., Hignite, C. E. (1980) Nature 283, 397–398[CrossRef][Medline] [Order article via Infotrieve]
  4. Reddy, J. K., Lalwani, N. D. (1983) CRC Crit. Rev. Toxicol. 12, 1–58[Medline] [Order article via Infotrieve]
  5. Nicholls-Grzemski, F. A., Calder, I. C., and Priestly, B. G. (1992) Biochem. Pharmacol. 7, 1395–1396
  6. Vanden Henvel, J. P. (1999) Toxicol. Sci. 47, 1–8[Abstract/Free Full Text]
  7. Yokota, S. (1993) Eur. J. Cell Biol. 61, 67–80[Medline] [Order article via Infotrieve]
  8. Subramani, S. (1998) Physiol. Rev. 78, 171–188[Abstract/Free Full Text]
  9. Farre, J. C., and Subramani, S. (2004) Trends Cell Biol. 14, 515–523[CrossRef][Medline] [Order article via Infotrieve]
  10. Kim, J., Kamada, Y., Stromhaug, P. E., Guan, J., Hefner-Gravink, A., Baba, M., Scott, S. V., Ohsumi, Y., Dunn, W. A., Jr., and Klionsky, D. J (2001) J. Cell Biol. 153, 381–396[Abstract/Free Full Text]
  11. Stromhaug, P. E., Bevan, A., and Dunn, W. A., Jr. (2001) J. Biol. Chem. 276, 42422–42435[Abstract/Free Full Text]
  12. Bellu, A. R., Komori, M., Klei, I. J., Kiel, J. A., and Veenhuis, M. (2001) J. Biol. Chem. 276, 44570–44574[Abstract/Free Full Text]
  13. Bellu, A. R., and Kiel, J. A. (2003) Microsc. Res. Tech. 61, 161–170[CrossRef][Medline] [Order article via Infotrieve]
  14. Ano, Y., Hattori, T., Oku, M., Mukaiyama, H., Baba, M., Ohsumi, Y., Kato, N., and Sakai, Y. (2005) Mol. Biol. Cell 16, 446–457[Abstract/Free Full Text]
  15. Klionsky, D. J., and Ohsumi, Y. (1999) Annu. Rev. Cell Dev. Biol. 15, 1–32[CrossRef][Medline] [Order article via Infotrieve]
  16. Kim, J., and Klionsky, D. J. (2000) Annu. Rev. Biochem. 69, 303–342[CrossRef][Medline] [Order article via Infotrieve]
  17. Kissova, I., Deffieu, M., Manon, S., and Camougrand, N. (2004) J. Biol. Chem. 279, 39068–39074[Abstract/Free Full Text]
  18. Lemasters, J. J. (2005) Rejuvenation Res. 8, 3–5[CrossRef][Medline] [Order article via Infotrieve]
  19. Tanida, I., Mizushima, N., Kiyooka, M., Ohsumi, M., Ueno, T., Ohsumi, Y., and Kominami, E. (1999) Mol. Biol. Cell 10, 1367–1379[Abstract/Free Full Text]
  20. Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., Kominami, E., Tanaka, K., and Chiba, T. (2005) J. Cell Biol. 169, 425–434[Abstract/Free Full Text]
  21. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., and Yoshimori, T. (2000) EMBO J. 19, 5720–5728[CrossRef][Medline] [Order article via Infotrieve]
  22. Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M. D., Klionsky, D. J., Ohsumi, M., and Ohsumi, Y. (1998) Nature 395, 395–398[CrossRef][Medline] [Order article via Infotrieve]
  23. Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., Mizushima, N., Tanida, I., Kominami, E., Ohsumi, M., Noda, T., and Ohsumi, Y. (2000) Nature 408, 488–492[CrossRef][Medline] [Order article via Infotrieve]
  24. Yuan, W., Stromhaug, P. E., and Dunn, W. A., Jr. (1999) Mol. Biol. Cell 10, 1353–1366[Abstract/Free Full Text]
  25. Tanida, I., Tanida-Miyake, E., Ueno, T., and Kominami, E. (2001) J. Biol. Chem. 276, 1701–1706[Abstract/Free Full Text]
  26. Tanida, I., Tanida-Miyake, E., Nishitani, T., Komatsu, M., Yamazaki, H., Ueno, T., and Kominami, E. (2002) Biochem. Biophys. Res. Commun. 292, 256–262[CrossRef][Medline] [Order article via Infotrieve]
  27. Tanida, I., Tanida-Miyake, E., Komatsu, M., Ueno, T., and Kominami, E. (2002) J. Biol. Chem. 277, 13739–13744[Abstract/Free Full Text]
  28. Asanuma, K., Tanida, I., Shirato, I., Ueno, T., Takahara, H., Nishitani, T., Kominami, E., and Tomino, Y. (2003) FASEB J. 17, 1165–1167[Abstract/Free Full Text]
  29. Tanida, I., Minematsu-Ikeguchi, N., Ueno, T., and Kominami, E. (2005) Autophagy 1, 84–91[Medline] [Order article via Infotrieve]
  30. de Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., and Appelmans, F. (1955) Biochem. J. 60, 604–617[Medline] [Order article via Infotrieve]
  31. Usuda, N., Yokota, S., Ichikawa, R., Hashimoto, T., and Nagata, T. (1991) J. Histochem. Cytochem. 39, 95–102[Abstract]
  32. Tsukamoto, T., Yokota, S., and Fujiki, Y. (1990) J. Cell Biol. 110, 651–660[Abstract/Free Full Text]
  33. Ezaki, J., Wolfe, L. S., Higuti, T., Ishidoh, K., and Kominami, E. (1995) J. Neurochem. 64, 733–741[Medline] [Order article via Infotrieve]
  34. Yokota, S., Oda, T., and Fahimi, H. D. (2001)) J. Histochem. Cytochem. 49, 613–621[Abstract/Free Full Text]
  35. Yokota, S. (2003) Microsc. Res. Tech. 61, 151–160[CrossRef][Medline] [Order article via Infotrieve]
  36. Shintani, T., and Klionsky, D. J. (2004) J. Biol. Chem. 279, 29889–29894[Abstract/Free Full Text]
  37. Onodera, J., and Ohsumi, Y. (2004) J. Biol. Chem. 279, 16071–16076[Abstract/Free Full Text]
  38. Nakagawa, I., Amano, A., Mizushima, N., Yamamoto, A., Yamaguchi, H., Kamimoto, T., Nara, A., Funao, J., Nakata, M., Tsuda, K., Hamada, S., and Yoshimori, T. (2004) Science 306, 1037–1040[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCBHome page
J. Geng, M. Baba, U. Nair, and D. J. Klionsky
Quantitative analysis of autophagy-related protein stoichiometry by fluorescence microscopy
J. Cell Biol., October 23, 2008; 182(1): 129 - 140.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
Y. Cao, H. Cheong, H. Song, and D. J. Klionsky
In vivo reconstitution of autophagy in Saccharomyces cerevisiae
J. Cell Biol., August 26, 2008; 182(4): 703 - 713.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
A. Melendez and T. P. Neufeld
The cell biology of autophagy in metazoans: a developing story
Development, July 15, 2008; 135(14): 2347 - 2360.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. K. Amaravadi and C. B. Thompson
The Roles of Therapy-Induced Autophagy and Necrosis in Cancer Treatment
Clin. Cancer Res., December 15, 2007; 13(24): 7271 - 7279.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
N. Mizushima
Autophagy: process and function
Genes & Dev., November 15, 2007; 21(22): 2861 - 2873.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/7/4035    most recent
M512283200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwata, J.-i.
Right arrow Articles by Kominami, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwata, J.-i.
Right arrow Articles by Kominami, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement